GSK180 is a selective, competitive, and highly potent inhibitor of kynurenine-3-monooxygenase (KMO), a critical enzyme in the tryptophan metabolic pathway, with an IC50 value of approximately 6 nM, displaying minimal off-target activity against other tryptophan pathway enzymes, rapidly altering kynurenine metabolite profiles, GSK180 serves as a powerful research tool for probing the biological and therapeutic implications of KMO inhibition in metabolic, neurological, and inflammatory disease models.
Molecular Weight:
276.07
CAS Number:
[1799725-26-0]
Formula:
C10H7Cl2NO4
Target:
Hydroxylase
T15426
T15426
* VAT and and shipping costs not included. Errors and price changes excepted
